16th Annual Scientific Meeting - Heart Failure Society of America
16th Annual Scientific Meeting - Heart Failure Society of America
16th Annual Scientific Meeting - Heart Failure Society of America
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Sept. 12<br />
Wednesday<br />
AM<br />
SYMPOSIUM<br />
Wednesday, September 12<br />
8:30-10:00 AM<br />
Ballroom 6A<br />
SYMPOSIUM<br />
Wednesday, September 12<br />
8:30-10:00 AM<br />
<strong>Meeting</strong> Room 608/609<br />
Sept. 12<br />
Wednesday<br />
AM<br />
WEDNESDAY<br />
Cardiotoxicity<br />
Moderators: Anju Nohria, Boston, MA<br />
Paul Rosenberg, Durham, NC<br />
8:30* Why So Many Tyrosine Kinases?<br />
Thomas Force, Philadelphia, PA<br />
8:45* Cardiac Effects <strong>of</strong> Cytokines<br />
Douglas L. Mann, St. Louis, MO<br />
9:00* Cardiomopathy <strong>of</strong> Substance Abuse<br />
George G. Philippides, Boston, MA<br />
9:15* Decreasing Toxicity <strong>of</strong> Anthracyclines<br />
Douglas B. Sawyer, Nashville, TN<br />
9:30* Toxicity <strong>of</strong> Nitric Oxide<br />
Mark T. Ziolo, Columbus, OH<br />
9:45* Cardiac Risk <strong>of</strong> High Intensity Exercise<br />
Joseph R. Libonati, Philadelphia, PA<br />
*12 minute presentation, 3 minute audience discussion<br />
Learning Objective: Evaluate heart failure patients for<br />
device implantation, manage implanted devices, and<br />
diagnose and treat pulmonary hypertension.<br />
Advances in Diagnosis and Targeted<br />
Management Strategies <strong>of</strong> Specific<br />
Cardiomyopathies<br />
Moderators: Edward M. Gilbert, Salt Lake City, UH<br />
Jacob Joseph, Boston, MA<br />
8:30 Current Management Strategies in Peripartum<br />
Cardiomopathy<br />
Uri Elkayam, Los Angeles, CA<br />
8:45 Host Factors in Human Viral Cardiomyopathy<br />
Toshitaka Yajima, La Jolla, CA<br />
9:00 Treatment <strong>of</strong> Thalassemia and Iron Load<br />
Cardiomyopathies: What is New?<br />
JonDavid Menteer, Los Angeles, CA<br />
9:15 Prevention and Monitoring <strong>of</strong> Chemotherapy Induced<br />
Cardiomyopathies<br />
Jean-Bernard Durand, Houston, TX<br />
9:30 Rhythm Devices for Sarcoidosis<br />
William H. Sauer, Aurora, CO<br />
9:45 Panel Discussion: Role <strong>of</strong> Registries for Specific<br />
Conditions<br />
WEDNESDAY<br />
Learning Objective: Diagnose selected cardiomyopathies<br />
and evaluate available treatment strategies.<br />
8:15 HFSA <strong>Annual</strong> Business <strong>Meeting</strong><br />
Room 608<br />
8:15 HFSA <strong>Annual</strong> Business <strong>Meeting</strong><br />
Room 608<br />
10:00 C<strong>of</strong>fee Break<br />
Refreshments served in Exhibit Hall 4B<br />
10:00 C<strong>of</strong>fee Break<br />
Refreshments served in Exhibit Hall 4B<br />
146 147
Change language